SlideShare uma empresa Scribd logo
1 de 48
D - DEATH
I - IS
C - COMING
DIC is an important contributor to
maternal mortality and morbidity
What is DIC ?
•DIC is a massive activation of
the coagulation system
leading to multiple clot
formation throughout the body.
•As a result there is rapid
consumption of clotting
factors which leads to
bleeding.
•So it is a paradoxical
condition characterised by
both thrombosis &
haemorrhage.
• DIC is a red flag for a severe
underlying disease
• DIC is never a primary diagnosis
• It is always a secondary diagnosis
INTRINSIC PATHWAY EXTRINSIC PATHWAY
XII XIIa VIIa
XIa
IXa
Ca
VIIIa
Xa (COMMON PATHWAY)
Prothrombin Thrombin
Plasmin
Fibrinogen Fibrin D-dimer
Plasmin
FDPs
Coagulation is always the initial
event
A delicate
balance exists
between
coagulation
mechanism &
fibrinolytic
system.
TRIGGER MECHANISMS OF DIC
DURING PREGNANCY
Pre- eclampsia
• Hypovolaemia
• Septicaemia
• Large foetomaternal
bleed
• Incompatible blood
transfusion
• Abruptio placentae
• Amniotic fluid
embolism
• Retained dead foetus
• Intrauterine sepsis
• H. mole
• Placenta accreta
• Abortion induced by
hypertonic fluids.
CLINICAL MANIFESTATIONS
• Bleeding from multiple sites ( most common )
( either oozing or frank bleeding)
• Renal dysfunction
• Hepatic dysfunction
• Respiratory dysfunction
• Shock and death
Diagonosis of DIC
• No single test diagnoses DIC
• Clinical picture leads to diagnosis of
DIC
Bed side Tests
• Clot Observation Test (CT)- if a firm clot
forms within 10 mins it is unlikely that pt has
DIC and that fibrinogen levels are normal.
• Clot Retraction Time-if the clot retracts well
by end of one hour it means the platelets are
adequate
• An unstable or fragile clot indicates presence
of FDPs in blood.
Lab parameters usually
associated with DIC are
Thrombocytopenia
Develops due to activation of clotting
system and consumption by clot formation
Sensitive but not specific
Fibrinogen degradation products
and D- Dimer
• It is the most sensitive test for DIC. (85-100%)
• It is unlikely to be DIC if FDP’s levels are normal.
• FDPs are metabolized in liver and kidney.
• Hepatic or renal dysfunction may lead to falsely
elevated levels of FDPs
PT & PTT
• PTT measures intrinsic pathway
• PT measures extrinsic pathway
• PT and PTT prolonged in 50-60% of DIC
cases
Can use PT and PTT to
monitor DIC
Fibrinogen
• Classically use to diagnose and
monitor DIC.
• Most cases not very helpful.
• Sensitivity of a low fibrinogen level for
the diagnosis of DIC is only 28%
Fibrinogen
• Fibrinogen is an acute-phase reactant so
may be falsely normal in DIC.
• Hypofibrinogenemia is detected only in very
severe cases of DIC.
• The blood fibrinogen level of 100mgm/100ml
is considered to be the critical level
Schistocytes (Fragmented RBCs)
•Fragmented red blood cells rarely constitute
>10% of the red cells.
•Neither sensitive nor specific to DIC.
Antithrombin & Protein C
• Antithrombin and protein C are often
reduced in DIC.
• Have shown to have both diagnostic and
prognostic significance .
DIC Scoring System
International Society
for thrombosis and
Haemostasis ( ISTH )
5 step diagnostic algorithm
Sensitivity 91%
Specificity 97%
ISTH Scoring System
Prerequisite
Does the patient have an
underlying disorder known to
be associated with overt DIC ?
NO
Do NOT use
this algorithm.
YES
Coagulation Tests
• Prothrombin time
• Platelet count
• Fibrinogen levels
• Fibrin related marker (FDPs, D-dimer)
Score Test Results
Prothrombin Time
<3 sec = 0
>3 but <6 sec = 1
>6 sec = 2
Platelet Count
> 100,000 /cumm = 0
50-100,000 /cumm = 1
< 50,000 /cumm = 2
Fibrinogen Level
•> 1 g / l = 0
•< 1 g / l = 1
Fibrin Marker (e.g. D-dimer, FDPs)
• No increase = 0
• Moderate increase = 2
• Strong increase = 3
Calculate score
• > or = to 5 compatible with overt DIC
• < 5 suggestive for non - overt DIC
PROTOCOL OF MANAGEMENT
• Maintenance of blood pressure and oxygenation
• Maintenance of blood volume (crystalloids,
albumin, plasma expanders).
• Blood Component therapy
• Treatment of underlying etiology of DIC
• Management of blood volume includes
prompt & adequate fluid replacement to prevent
renal shutdown.
• Crystalloids (Ringer lactate) / Haemaccel
• Colloids X
Whatever fluid is used, it only acts as a stop gap
until suitable blood component therapy is
available
Blood component therapy
• Fresh frozen plasma
• Cryoprecipitate
• Platelets
• Packed red blood cells
Packed red blood cells
• Are most effective to improve oxygen carrying
capacity
• Each unit contains about 300 ml ( 250 ml RBC &
50 ml plasma)
• One unit of PRBC raises the Hb by 1 gm/dl and
PCV by 3 %.
Platelet concentrates
• Platelets should be given rapidly over 10 mins.
• One unit raises the count between 5000 –
10,000/ ml.
• Dose is = one unit / 10 kg.
• single donor concentrates are preferred as the
antigenic risk is low.
• Platelets count can be assessed 10 – 60 mins
after transfusion.
Fresh Frozen Plasma (FFP)
• Provides both volume & coagulation factor
replacement.
• One unit of FFP (250 ml) raises fibrinogen by
5 – 10 mgm /dl.
• Dose 10 – 15 ml/ kg or one bag / 10 kg
Cryoprecipitate
• It is rich in fibrinogen so its use is indicated if blood
fibrinogen levels are < 1 gm / L.
• One unit increases the fibrinogen level by 5- 10
mg/dl.
• Dose is 1 unit/ 5 kg.
• No. of bags required is =0.2 x body weight in kg.
The main therapeutic goal is
to maintain
• Hb > 8 gm / L
• Platelet count > 75 ,000 / cumm
• Prothrombin time < 1.5 times the normal
• Activated prothrombin time < 1.5
• Fibrinogen > 1.0 gm / L
Treatment of the
underlying condition
PLACENTAL ABRUPTION--
• The severity of DIC is directly related to
time interval between the placental
separation and delivery
• Management thus includes emptying the
uterus as soon as possible
PRE ECLAMPSIA- ECCLAMPSIA
SYNDROME
• Majority of women with pre-ecclampsia have
sub-clinical consumptive coagulopathy.
• Frank DIC is seen when there is associated
placental abruption or HELLP syndrome.
Immediate delivery is recommended
AMNIOTIC FLUID EMBOLISM
• Carries high maternal mortality (80%)
• Treatment is mainly supportive as there is no
proven effective therapy.
• Heparin may be considered (80-100 units /kg s/c
4-6 hly )
INTRAUTERINE FETAL DEMISE
• Goal: to raise fibrinogen level to 200-300
mg/dL before termination of pregnancy.
• Heparin may be considered for chronic DIC
associated with IUD
SEPSIS
• Intensive antibiotic therapy followed by
evacuation of uterine contents.
• Prompt restoration and maintenance of
circulation.
• Removal of septic focus
To conclude
The only proven treatment of DIC
Stop the triggering
process .
CRITICAL CARE
CAN MAKE A GREAT DIFFERENCE
ALERT MIND !
TIMELY INTERVENTION !
AGGRESSIVE MANAGEMENT !
Normal values of blood
coagulation profile
Prothrombin time(11-16s)-Extr.pathway
• PTT-(30-45s) –Intrinsic pathway
• Thrombin time (TT) 10-15s
• S. Fibrinogen- (300-600mg%)
• Platelets (1.5-3.0L)
• D-dimer (<0.5mg/L) 0-200mgm/ml
Fibrin degradation products (10µ/dl) 0-5 microgm/ml

Mais conteúdo relacionado

Mais procurados

Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
jasonbartsch
 

Mais procurados (20)

Mechanism of clotting
Mechanism of clottingMechanism of clotting
Mechanism of clotting
 
Coagulopathy
CoagulopathyCoagulopathy
Coagulopathy
 
Amniotic fluid embolism
Amniotic fluid embolismAmniotic fluid embolism
Amniotic fluid embolism
 
Amniotic fluid embolism
Amniotic fluid embolism Amniotic fluid embolism
Amniotic fluid embolism
 
Obstetrical emergencies
Obstetrical emergenciesObstetrical emergencies
Obstetrical emergencies
 
Hemostatsis & blood transfusion
Hemostatsis & blood transfusionHemostatsis & blood transfusion
Hemostatsis & blood transfusion
 
5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards
 
Bleeding and coagulopathy
Bleeding and coagulopathyBleeding and coagulopathy
Bleeding and coagulopathy
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Post-partum haemorrhage
Post-partum haemorrhagePost-partum haemorrhage
Post-partum haemorrhage
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Hematologic emergency
Hematologic emergencyHematologic emergency
Hematologic emergency
 
Principles of Blood products tranfusion
Principles of Blood products tranfusionPrinciples of Blood products tranfusion
Principles of Blood products tranfusion
 
Lab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra pLab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra p
 
Anticoagulants & coagulation disorders
Anticoagulants & coagulation disordersAnticoagulants & coagulation disorders
Anticoagulants & coagulation disorders
 
Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2Coagulation abnormalities in critically ill patients 2
Coagulation abnormalities in critically ill patients 2
 
HEMOPHILIA THE ROYAL DISEASE
HEMOPHILIA THE ROYAL DISEASEHEMOPHILIA THE ROYAL DISEASE
HEMOPHILIA THE ROYAL DISEASE
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
A Review On Hematology and Oncology Emergencies
A Review On Hematology and Oncology EmergenciesA Review On Hematology and Oncology Emergencies
A Review On Hematology and Oncology Emergencies
 
Bleeding disorders in women
Bleeding disorders in womenBleeding disorders in women
Bleeding disorders in women
 

Destaque

How to Decrease Hysterectomy Rate In India
How to Decrease Hysterectomy Rate In India How to Decrease Hysterectomy Rate In India
How to Decrease Hysterectomy Rate In India
Lifecare Centre
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Lifecare Centre
 
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Lifecare Centre
 
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
Lifecare Centre
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisited
Lifecare Centre
 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccination
Lifecare Centre
 
Placenta accreta lessons learnt
Placenta accreta lessons learntPlacenta accreta lessons learnt
Placenta accreta lessons learnt
Lifecare Centre
 
Genetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jainGenetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jain
Lifecare Centre
 
Good health working w new 2013
Good health   working w new 2013Good health   working w new 2013
Good health working w new 2013
Lifecare Centre
 
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
Lifecare Centre
 
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
Lifecare Centre
 

Destaque (20)

How to Decrease Hysterectomy Rate In India
How to Decrease Hysterectomy Rate In India How to Decrease Hysterectomy Rate In India
How to Decrease Hysterectomy Rate In India
 
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal Practical tips for monitoring  of  an iui cycle Dr. Jyoti Agarwal
Practical tips for monitoring of an iui cycle Dr. Jyoti Agarwal
 
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
 
1. Antenatal screening updates
1. Antenatal screening updates1. Antenatal screening updates
1. Antenatal screening updates
 
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
1 iui a z, including techniques of iui & lps Dr. Sharda jain & Team
 
Luteal phase support in art - revisited
Luteal phase support in art  - revisitedLuteal phase support in art  - revisited
Luteal phase support in art - revisited
 
Uterine balloon tharepy
Uterine balloon tharepyUterine balloon tharepy
Uterine balloon tharepy
 
An ohss – free clinic
An ohss – free clinicAn ohss – free clinic
An ohss – free clinic
 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccination
 
Placenta accreta lessons learnt
Placenta accreta lessons learntPlacenta accreta lessons learnt
Placenta accreta lessons learnt
 
Genetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jainGenetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jain
 
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
 
Good health working w new 2013
Good health   working w new 2013Good health   working w new 2013
Good health working w new 2013
 
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
WHAT EVERY GYNAECOLOGIST SHOULD KNOW ABOUT MALE INFERTILITY ?? Mission : Male...
 
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)    Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
Recurrent Pregnancy Loss Sharing Personal Experience (10 years)
 
CONTROVERSIES in INDUCTION OF LABOR Dr. Dipti Nabh , Dr. Sharda Jain
CONTROVERSIES in INDUCTION OF LABOR Dr. Dipti Nabh , Dr. Sharda Jain CONTROVERSIES in INDUCTION OF LABOR Dr. Dipti Nabh , Dr. Sharda Jain
CONTROVERSIES in INDUCTION OF LABOR Dr. Dipti Nabh , Dr. Sharda Jain
 
Insight AUB Management Guidelines on AUB in Reproductive Period
Insight AUB Management Guidelines  on AUB  in Reproductive PeriodInsight AUB Management Guidelines  on AUB  in Reproductive Period
Insight AUB Management Guidelines on AUB in Reproductive Period
 
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
 
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
Obesity in female infertility by dr. sharda jain, Dr. jyoti Agarwal , Dr. Jyo...
 
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine BleedingD.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
 

Semelhante a Abc critical care of dic dr. jyoti agarwal

DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
Lifecare Centre
 
Transfusion support in neonates and paediatric patients [autosaved]
Transfusion support in neonates and paediatric patients [autosaved]Transfusion support in neonates and paediatric patients [autosaved]
Transfusion support in neonates and paediatric patients [autosaved]
Figo Khan
 

Semelhante a Abc critical care of dic dr. jyoti agarwal (20)

DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
DIC Drill Dr, jyoti Agarwal , Dr. Sgarda jain
 
DIC.ppt
DIC.pptDIC.ppt
DIC.ppt
 
Fluid and blood in obstetric
Fluid and blood in obstetricFluid and blood in obstetric
Fluid and blood in obstetric
 
Transfusion support in neonates and paediatric patients [autosaved]
Transfusion support in neonates and paediatric patients [autosaved]Transfusion support in neonates and paediatric patients [autosaved]
Transfusion support in neonates and paediatric patients [autosaved]
 
Anaesthetic management of obstetric emergencies
Anaesthetic management of  obstetric emergenciesAnaesthetic management of  obstetric emergencies
Anaesthetic management of obstetric emergencies
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Disseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdfDisseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdf
 
Blood component theraphy
Blood component theraphyBlood component theraphy
Blood component theraphy
 
Thrombocytopenia & Seizures.pptx
Thrombocytopenia & Seizures.pptxThrombocytopenia & Seizures.pptx
Thrombocytopenia & Seizures.pptx
 
blood components therapy
 blood components therapy blood components therapy
blood components therapy
 
BLOOD TRANSFUSION AR.pptx
BLOOD TRANSFUSION AR.pptxBLOOD TRANSFUSION AR.pptx
BLOOD TRANSFUSION AR.pptx
 
BloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdfBloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdf
 
blood products
blood products blood products
blood products
 
blood and blood products
blood and blood productsblood and blood products
blood and blood products
 
Thrombocytopaenia in pregnancy
Thrombocytopaenia in pregnancyThrombocytopaenia in pregnancy
Thrombocytopaenia in pregnancy
 
BLOOD TRANSFUSION PPT.pdf
BLOOD TRANSFUSION PPT.pdfBLOOD TRANSFUSION PPT.pdf
BLOOD TRANSFUSION PPT.pdf
 
Transfusion and blood component therapy
Transfusion and  blood component therapyTransfusion and  blood component therapy
Transfusion and blood component therapy
 
bloodcomponentcopy-120503122109-phpapp01.pptx
bloodcomponentcopy-120503122109-phpapp01.pptxbloodcomponentcopy-120503122109-phpapp01.pptx
bloodcomponentcopy-120503122109-phpapp01.pptx
 
Transfusion reactions and blood products
Transfusion reactions and blood productsTransfusion reactions and blood products
Transfusion reactions and blood products
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 

Mais de Lifecare Centre

Mais de Lifecare Centre (20)

The Newer Concepts In Endometriosis Management : Dr Sharda Jain
The Newer Concepts In Endometriosis  Management : Dr Sharda JainThe Newer Concepts In Endometriosis  Management : Dr Sharda Jain
The Newer Concepts In Endometriosis Management : Dr Sharda Jain
 
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
 
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
Liver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda JainLiver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda Jain
 
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
 
Strategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PARTStrategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PART
 
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
 
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda JainVaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
 
How to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda JainHow to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda Jain
 
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda JainSOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
 
White Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda JainWhite Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda Jain
 
White Coat hypertension Why it is Important? : Dr Sharda Jain
White Coat hypertension Why it is  Important? : Dr Sharda JainWhite Coat hypertension Why it is  Important? : Dr Sharda Jain
White Coat hypertension Why it is Important? : Dr Sharda Jain
 
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda JainUnderstanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
 
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda JainKnow Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
 
Still Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainStill Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda Jain
 
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
 
Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its ...
Iron Deficiency Anemia in PregnancyRole of IV Ferric Carboxymaltose andits ...Iron Deficiency Anemia in PregnancyRole of IV Ferric Carboxymaltose andits ...
Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its ...
 
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
 

Último

Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Último (20)

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
 

Abc critical care of dic dr. jyoti agarwal

  • 1.
  • 2. D - DEATH I - IS C - COMING DIC is an important contributor to maternal mortality and morbidity
  • 3. What is DIC ? •DIC is a massive activation of the coagulation system leading to multiple clot formation throughout the body. •As a result there is rapid consumption of clotting factors which leads to bleeding. •So it is a paradoxical condition characterised by both thrombosis & haemorrhage.
  • 4. • DIC is a red flag for a severe underlying disease • DIC is never a primary diagnosis • It is always a secondary diagnosis
  • 5. INTRINSIC PATHWAY EXTRINSIC PATHWAY XII XIIa VIIa XIa IXa Ca VIIIa Xa (COMMON PATHWAY) Prothrombin Thrombin Plasmin Fibrinogen Fibrin D-dimer Plasmin FDPs
  • 6. Coagulation is always the initial event A delicate balance exists between coagulation mechanism & fibrinolytic system.
  • 7. TRIGGER MECHANISMS OF DIC DURING PREGNANCY Pre- eclampsia • Hypovolaemia • Septicaemia • Large foetomaternal bleed • Incompatible blood transfusion • Abruptio placentae • Amniotic fluid embolism • Retained dead foetus • Intrauterine sepsis • H. mole • Placenta accreta • Abortion induced by hypertonic fluids.
  • 8. CLINICAL MANIFESTATIONS • Bleeding from multiple sites ( most common ) ( either oozing or frank bleeding) • Renal dysfunction • Hepatic dysfunction • Respiratory dysfunction • Shock and death
  • 9. Diagonosis of DIC • No single test diagnoses DIC • Clinical picture leads to diagnosis of DIC
  • 10. Bed side Tests • Clot Observation Test (CT)- if a firm clot forms within 10 mins it is unlikely that pt has DIC and that fibrinogen levels are normal. • Clot Retraction Time-if the clot retracts well by end of one hour it means the platelets are adequate • An unstable or fragile clot indicates presence of FDPs in blood.
  • 11. Lab parameters usually associated with DIC are Thrombocytopenia Develops due to activation of clotting system and consumption by clot formation Sensitive but not specific
  • 12. Fibrinogen degradation products and D- Dimer • It is the most sensitive test for DIC. (85-100%) • It is unlikely to be DIC if FDP’s levels are normal. • FDPs are metabolized in liver and kidney. • Hepatic or renal dysfunction may lead to falsely elevated levels of FDPs
  • 13. PT & PTT • PTT measures intrinsic pathway • PT measures extrinsic pathway • PT and PTT prolonged in 50-60% of DIC cases Can use PT and PTT to monitor DIC
  • 14. Fibrinogen • Classically use to diagnose and monitor DIC. • Most cases not very helpful. • Sensitivity of a low fibrinogen level for the diagnosis of DIC is only 28%
  • 15. Fibrinogen • Fibrinogen is an acute-phase reactant so may be falsely normal in DIC. • Hypofibrinogenemia is detected only in very severe cases of DIC. • The blood fibrinogen level of 100mgm/100ml is considered to be the critical level
  • 16. Schistocytes (Fragmented RBCs) •Fragmented red blood cells rarely constitute >10% of the red cells. •Neither sensitive nor specific to DIC.
  • 17. Antithrombin & Protein C • Antithrombin and protein C are often reduced in DIC. • Have shown to have both diagnostic and prognostic significance .
  • 18. DIC Scoring System International Society for thrombosis and Haemostasis ( ISTH )
  • 19. 5 step diagnostic algorithm Sensitivity 91% Specificity 97%
  • 20. ISTH Scoring System Prerequisite Does the patient have an underlying disorder known to be associated with overt DIC ?
  • 21. NO
  • 22. Do NOT use this algorithm.
  • 23. YES
  • 24. Coagulation Tests • Prothrombin time • Platelet count • Fibrinogen levels • Fibrin related marker (FDPs, D-dimer)
  • 26. Prothrombin Time <3 sec = 0 >3 but <6 sec = 1 >6 sec = 2
  • 27. Platelet Count > 100,000 /cumm = 0 50-100,000 /cumm = 1 < 50,000 /cumm = 2
  • 28. Fibrinogen Level •> 1 g / l = 0 •< 1 g / l = 1
  • 29. Fibrin Marker (e.g. D-dimer, FDPs) • No increase = 0 • Moderate increase = 2 • Strong increase = 3
  • 30. Calculate score • > or = to 5 compatible with overt DIC • < 5 suggestive for non - overt DIC
  • 31. PROTOCOL OF MANAGEMENT • Maintenance of blood pressure and oxygenation • Maintenance of blood volume (crystalloids, albumin, plasma expanders). • Blood Component therapy • Treatment of underlying etiology of DIC
  • 32. • Management of blood volume includes prompt & adequate fluid replacement to prevent renal shutdown. • Crystalloids (Ringer lactate) / Haemaccel • Colloids X Whatever fluid is used, it only acts as a stop gap until suitable blood component therapy is available
  • 33. Blood component therapy • Fresh frozen plasma • Cryoprecipitate • Platelets • Packed red blood cells
  • 34. Packed red blood cells • Are most effective to improve oxygen carrying capacity • Each unit contains about 300 ml ( 250 ml RBC & 50 ml plasma) • One unit of PRBC raises the Hb by 1 gm/dl and PCV by 3 %.
  • 35. Platelet concentrates • Platelets should be given rapidly over 10 mins. • One unit raises the count between 5000 – 10,000/ ml. • Dose is = one unit / 10 kg. • single donor concentrates are preferred as the antigenic risk is low. • Platelets count can be assessed 10 – 60 mins after transfusion.
  • 36. Fresh Frozen Plasma (FFP) • Provides both volume & coagulation factor replacement. • One unit of FFP (250 ml) raises fibrinogen by 5 – 10 mgm /dl. • Dose 10 – 15 ml/ kg or one bag / 10 kg
  • 37. Cryoprecipitate • It is rich in fibrinogen so its use is indicated if blood fibrinogen levels are < 1 gm / L. • One unit increases the fibrinogen level by 5- 10 mg/dl. • Dose is 1 unit/ 5 kg. • No. of bags required is =0.2 x body weight in kg.
  • 38. The main therapeutic goal is to maintain • Hb > 8 gm / L • Platelet count > 75 ,000 / cumm • Prothrombin time < 1.5 times the normal • Activated prothrombin time < 1.5 • Fibrinogen > 1.0 gm / L
  • 40. PLACENTAL ABRUPTION-- • The severity of DIC is directly related to time interval between the placental separation and delivery • Management thus includes emptying the uterus as soon as possible
  • 41. PRE ECLAMPSIA- ECCLAMPSIA SYNDROME • Majority of women with pre-ecclampsia have sub-clinical consumptive coagulopathy. • Frank DIC is seen when there is associated placental abruption or HELLP syndrome. Immediate delivery is recommended
  • 42. AMNIOTIC FLUID EMBOLISM • Carries high maternal mortality (80%) • Treatment is mainly supportive as there is no proven effective therapy. • Heparin may be considered (80-100 units /kg s/c 4-6 hly )
  • 43. INTRAUTERINE FETAL DEMISE • Goal: to raise fibrinogen level to 200-300 mg/dL before termination of pregnancy. • Heparin may be considered for chronic DIC associated with IUD
  • 44. SEPSIS • Intensive antibiotic therapy followed by evacuation of uterine contents. • Prompt restoration and maintenance of circulation. • Removal of septic focus
  • 45. To conclude The only proven treatment of DIC Stop the triggering process .
  • 46. CRITICAL CARE CAN MAKE A GREAT DIFFERENCE ALERT MIND ! TIMELY INTERVENTION ! AGGRESSIVE MANAGEMENT !
  • 47.
  • 48. Normal values of blood coagulation profile Prothrombin time(11-16s)-Extr.pathway • PTT-(30-45s) –Intrinsic pathway • Thrombin time (TT) 10-15s • S. Fibrinogen- (300-600mg%) • Platelets (1.5-3.0L) • D-dimer (<0.5mg/L) 0-200mgm/ml Fibrin degradation products (10µ/dl) 0-5 microgm/ml